Live: Will Adobe Smash Q2 Earnings After the Bell Tonight?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 6, 2019 at 11:50 AM EDT

New Cellulite Study Submission Could Be a Big Hit

Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA…

Hristina Byrnes | Sep 6, 2019 at 10:51 AM EDT

Peanut Allergy Can Be Treated With the Very Thing That Causes It

An estimated 1.8 million children in the U.S. have a potentially life-threatening allergy to peanuts. (According to the National Institutes…

Jon C. Ogg | Sep 5, 2019 at 2:00 PM EDT

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

NextCure appears to be one of those companies that has flown under the radar of the investing community since its…

Chris Lange | Sep 5, 2019 at 1:15 PM EDT

Why This Analyst Sees Cidara Nearly Doubling

While just announced huge deal seems to be the big break that Cidara Therapeutics needs, one analyst believes this stock…

Chris Lange | Sep 5, 2019 at 10:20 AM EDT

Breakthrough Sickle Cell Disease Treatment Is on the Way

GBT shares jumped on Thursday after the company announced that the FDA has accepted for filing the company’s New Drug…

Paul Ausick | Sep 5, 2019 at 7:50 AM EDT

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Shares of drugmaker Mallinckrodt have lost more than 40% overnight following reports that the firm has hired restructuring advisors. A…

Hristina Byrnes | Sep 5, 2019 at 7:29 AM EDT

It’s Easy to Overdose on Acetaminophen and It Can Kill You, New Study Says

A popular pain-killer, generally considered safe and effective, can turn toxic and even deadly if it’s overused — a concern…

Chris Lange | Sep 4, 2019 at 10:35 AM EDT

What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases

Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off…

Chris Lange | Sep 3, 2019 at 12:45 PM EDT

What Ardelyx’s Successful Hyperphosphatemia Study Means for CKD Patients

Ardelyx shares jumped on Tuesday after the firm announced positive results from its late-stage study in dialysis patients who have…

Paul Ausick | Sep 3, 2019 at 12:35 PM EDT

FDA, CDC Step Up Investigations Into Vaping

Following more than 200 reports of respiratory illness and one death possibly linked to using e-cigarettes, the U.S. FDA and…

Chris Lange | Sep 3, 2019 at 12:25 PM EDT

Here’s the Big Break for Cidara’s Fungal Infection Study

Cidara Therapeutics shares saw a massive gain on Tuesday after the firm announced that it has entered into a strategic…

Jon C. Ogg | Sep 3, 2019 at 12:20 PM EDT

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.

Chris Lange | Sep 3, 2019 at 10:50 AM EDT

Why This Late-Stage LDL-Cholesterol Study Could Be a Big Hit

Medicines Co. shares made a handy gain on Tuesday after the firm announced results from its late-stage trial in the…

Mike Sauter | Aug 30, 2019 at 11:51 AM EDT

It Might Be Possible to Identify Mental Illness With an Online Test

Mental illness is a pervasive problem nationwide. According to this infographic on mental health facts in America published by the…

Jon C. Ogg | Aug 29, 2019 at 2:00 PM EDT

Is Mallinckrodt Running Out of Options?

Mallinckrodt is a pharmaceutical player that has been in trouble over its role in the opioid crisis in America. Investors…

1 … 86 87 88 89 90 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

New Cellulite Study Submission Could Be a Big Hit

Peanut Allergy Can Be Treated With the Very Thing That Causes It

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Why This Analyst Sees Cidara Nearly Doubling

Breakthrough Sickle Cell Disease Treatment Is on the Way

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

It’s Easy to Overdose on Acetaminophen and It Can Kill You, New Study Says

What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases

What Ardelyx’s Successful Hyperphosphatemia Study Means for CKD Patients

FDA, CDC Step Up Investigations Into Vaping

Here’s the Big Break for Cidara’s Fungal Infection Study

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

Why This Late-Stage LDL-Cholesterol Study Could Be a Big Hit

It Might Be Possible to Identify Mental Illness With an Online Test

Is Mallinckrodt Running Out of Options?

Live: Will Adobe Smash Q2 Earnings After the Bell Tonight?

Live: Will RH Crush Q1 Earnings After the Market Closes Tonight?

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

The Surprising Reason Wednesday’s CPI Numbers Could be Good for Warsh and Bad for Social Security

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

Health and Healthcare Articles

All Health and Healthcare Articles

New Cellulite Study Submission Could Be a Big Hit

Peanut Allergy Can Be Treated With the Very Thing That Causes It

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Why This Analyst Sees Cidara Nearly Doubling

Breakthrough Sickle Cell Disease Treatment Is on the Way

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

It’s Easy to Overdose on Acetaminophen and It Can Kill You, New Study Says

What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases

What Ardelyx’s Successful Hyperphosphatemia Study Means for CKD Patients

FDA, CDC Step Up Investigations Into Vaping

Here’s the Big Break for Cidara’s Fungal Infection Study

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

Why This Late-Stage LDL-Cholesterol Study Could Be a Big Hit

It Might Be Possible to Identify Mental Illness With an Online Test

Is Mallinckrodt Running Out of Options?

Live: Will Adobe Smash Q2 Earnings After the Bell Tonight?

Live: Will RH Crush Q1 Earnings After the Market Closes Tonight?

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

The Surprising Reason Wednesday’s CPI Numbers Could be Good for Warsh and Bad for Social Security

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip